Financial results - ADAVET-FARMAXIA SRL

Financial Summary - Adavet-Farmaxia Srl
Unique identification code: 33716139
Registration number: J40/12160/2014
Nace: 7500
Sales - Ron
1.795.566
Net Profit - Ron
139.867
Employees
14
Open Account
Company Adavet-Farmaxia Srl with Fiscal Code 33716139 recorded a turnover of 2024 of 1.795.566, with a net profit of 139.867 and having an average number of employees of 14. The company operates in the field of Activităţi veterinare having the NACE code 7500.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Adavet-Farmaxia Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 241.661 284.216 340.633 725.060 837.180 981.316 1.397.152 1.509.979 1.619.872 1.795.566
Total Income - EUR 250.386 288.799 347.478 736.589 847.704 996.424 1.407.024 1.533.849 1.627.154 1.814.201
Total Expenses - EUR 213.468 258.924 337.215 717.692 767.539 884.169 1.266.613 1.398.581 1.592.741 1.649.151
Gross Profit/Loss - EUR 36.918 29.875 10.263 18.897 80.165 112.255 140.411 135.268 34.413 165.051
Net Profit/Loss - EUR 31.364 25.078 6.869 11.530 71.687 103.032 125.424 113.273 27.778 139.867
Employees 3 3 4 8 9 9 10 12 12 14
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 11.5%, from 1.619.872 euro in the year 2023, to 1.795.566 euro in 2024. The Net Profit increased by 112.244 euro, from 27.778 euro in 2023, to 139.867 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Adavet-Farmaxia Srl

Rating financiar

Financial Rating -
ADAVET-FARMAXIA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Adavet-Farmaxia Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Adavet-Farmaxia Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Adavet-Farmaxia Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Adavet-Farmaxia Srl - CUI 33716139

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets -2 -2 4.873 4.185 41.389 30.122 41.098 28.262 70.670 48.981
Current Assets 44.541 52.542 120.636 89.209 149.328 243.041 359.164 398.866 385.798 544.359
Inventories 16.812 46.837 108.609 59.265 123.764 226.222 289.910 354.467 328.344 480.149
Receivables 3.399 3.832 9.602 5.400 3.014 7.671 12.746 18.033 41.113 42.955
Cash 24.331 1.872 2.424 24.544 22.218 8.642 55.846 25.067 16.341 21.254
Shareholders Funds 28.876 25.132 31.575 42.526 113.400 202.643 323.573 253.360 198.185 334.541
Social Capital 45 45 44 43 53 52 51 51 51 50
Debts 15.664 27.408 97.509 54.414 97.699 97.503 110.610 176.646 259.206 259.624
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7500 - 7500"
CAEN Financial Year 7500
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 544.359 euro in 2024 which includes Inventories of 480.149 euro, Receivables of 42.955 euro and cash availability of 21.254 euro.
The company's Equity was valued at 334.541 euro, while total Liabilities amounted to 259.624 euro. Equity increased by 137.464 euro, from 198.185 euro in 2023, to 334.541 in 2024.

Risk Reports Prices

Reviews - Adavet-Farmaxia Srl

Comments - Adavet-Farmaxia Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.